Gene amplifications of AKT2 occur in 2.8% up to 4% of human breast carcinomas, although the number of breast cancer samples with amplified AKT2 is lower than in ovarian cancer [75, 82]. The gene discussed is AKT2; the disease is ovarian carcinoma.